-
Something wrong with this record ?
Determination of critical parameters of drug substance influencing dissolution: a case study
E. Bojnanska, M. Kalina, L. Parizek, E. Bartonickova, T. Opravil, M. Vesely, M. Pekar, J. Jampilek,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2013
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2012-12-04
Open Access Digital Library
from 2013-01-01
CINAHL Plus with Full Text (EBSCOhost)
from 2013-01-01
Medline Complete (EBSCOhost)
from 2013-01-01
Health & Medicine (ProQuest)
from 2013
Wiley-Blackwell Open Access Titles
from 2001
ROAD: Directory of Open Access Scholarly Resources
from 2013
PubMed
25317424
DOI
10.1155/2014/929248
Knihovny.cz E-resources
- MeSH
- Chemical Phenomena * MeSH
- Microscopy, Electron, Scanning MeSH
- Solubility MeSH
- Drug Liberation * MeSH
- Particle Size MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The purpose of this study was to specify critical parameters (physicochemical characteristics) of drug substance that can affect dissolution profile/dissolution rate of the final drug product manufactured by validated procedure from various batches of the same drug substance received from different suppliers. The target was to design a sufficiently robust drug substance specification allowing to obtain a satisfactory drug product. For this reason, five batches of the drug substance and five samples of the final peroral drug products were analysed with the use of solid state analysis methods on the bulk level. Besides polymorphism, particle size distribution, surface area, zeta potential, and water content were identified as important parameters, and the zeta potential and the particle size distribution of the drug substance seem to be critical quality attributes affecting the dissolution rate of the drug substance released from the final peroral drug formulation.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031783
- 003
- CZ-PrNML
- 005
- 20151008114024.0
- 007
- ta
- 008
- 151005s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/929248 $2 doi
- 035 __
- $a (PubMed)25317424
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bojnanska, Erika $u Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1/3, 612 42 Brno, Czech Republic.
- 245 10
- $a Determination of critical parameters of drug substance influencing dissolution: a case study / $c E. Bojnanska, M. Kalina, L. Parizek, E. Bartonickova, T. Opravil, M. Vesely, M. Pekar, J. Jampilek,
- 520 9_
- $a The purpose of this study was to specify critical parameters (physicochemical characteristics) of drug substance that can affect dissolution profile/dissolution rate of the final drug product manufactured by validated procedure from various batches of the same drug substance received from different suppliers. The target was to design a sufficiently robust drug substance specification allowing to obtain a satisfactory drug product. For this reason, five batches of the drug substance and five samples of the final peroral drug products were analysed with the use of solid state analysis methods on the bulk level. Besides polymorphism, particle size distribution, surface area, zeta potential, and water content were identified as important parameters, and the zeta potential and the particle size distribution of the drug substance seem to be critical quality attributes affecting the dissolution rate of the drug substance released from the final peroral drug formulation.
- 650 12
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a mikroskopie elektronová rastrovací $7 D008855
- 650 _2
- $a velikost částic $7 D010316
- 650 12
- $a chemické jevy $7 D055598
- 650 _2
- $a rozpustnost $7 D012995
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kalina, Michal $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Parizek, Ladislav $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Bartonickova, Eva $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Opravil, Tomas $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Vesely, Michal $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Pekar, Miloslav $u Faculty of Chemistry, Brno University of Technology, Purkynova 464/118, 612 00 Brno, Czech Republic.
- 700 1_
- $a Jampilek, Josef $u Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackeho 1/3, 612 42 Brno, Czech Republic.
- 773 0_
- $w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2014, č. - (2014), s. 929248
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25317424 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151008114210 $b ABA008
- 999 __
- $a ok $b bmc $g 1092659 $s 914909
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 929248 $e 20140915 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
- LZP __
- $a Pubmed-20151005